Immunology and Immunotherapy
A section of Biomedicines (ISSN 2227-9059).
Section Information
This section publishes reviews and original peer-reviewed papers of a high scientific level covering all the aspects of immunology and oncoImmunology. Papers aim to uncover the modulations of the immune system, active and passive immunotherapies, the diagnostic test based on specific markers and the use of new technologies to identify novel predictive factors to respond to immunotherapy. Topics include, but are not limited to in vivo/in vitro immune responses research; targeted therapies (including antibody research and vaccine research); virotherapy and oncolytic vaccines; use of nanoparticles and microvesicles for developing immunotherapeutics; etc.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- 10th Anniversary of Biomedicines-Immune-Aging (Deadline: 15 June 2023)
- 10th Anniversary of Biomedicines: The Development of Cancer Immunotherapy (Deadline: 30 June 2023)
- Basic and Clinical Researches of Antiphospholipid Syndrome (Deadline: 30 June 2023)
- Photodynamic Therapy 2.0 (Deadline: 30 June 2023)
- Neutrophil Extracellular Traps (NETs) in Immunity (Deadline: 30 June 2023)
- Advances in Respiratory Allergies (Deadline: 30 June 2023)
- Impact of COVID-19 on Skin Diseases (Deadline: 30 June 2023)
- Molecular Research on Human Immunodeficiency Virus (HIV) (Deadline: 30 June 2023)
- Immune Dysfunction in Brain Disorders (Deadline: 30 June 2023)
- The Role of the Immune System in Systemic Sclerosis (Deadline: 30 June 2023)
- Crohn's Disease and Ulcerative Colitis: From Pathophysiology to Novel Therapeutic Approaches (Deadline: 30 June 2023)
- Immunology: You Can't Make a Silk Purse Out of a Sow's Ear (Deadline: 30 June 2023)
- Immunomodulation and Development of Immunotherapies for Human Autoimmunity, Inflammation, Infection, Allergy, and Cancer (Deadline: 30 June 2023)
- New Advances in Sjögren's Syndrome: Towards Novel Therapeutic Approaches (Deadline: 30 June 2023)
- Poxviruses: From Pathophysiology to Novel Therapeutic Approaches (Deadline: 30 June 2023)
- Angiogenesis and Inflammation in Biological Barriers 3.0 (Deadline: 15 July 2023)
- Emerging Issues in Vaccine for COVID (Deadline: 15 July 2023)
- The Impact of Oral Microbiota-Immunity Axis in Oral and Systemic Diseases (Deadline: 15 July 2023)
- Metabolism Research in Tumor-Associated Macrophages (Deadline: 31 July 2023)
- Immunosuppressive Signaling Regulation in Cancer Development 2.0 (Deadline: 31 July 2023)
- Emerging Viral Infectious Diseases: Immunology, Therapeutics and Prevention in Post Pandemic Era (Deadline: 31 July 2023)
- Relationship between Serum Metabolites and Oxidative Stress, Inflammation, and Gut Microbiota (Deadline: 31 July 2023)
- Inflammation and Immunosenescence in Age-Related Diseases (Deadline: 31 July 2023)
- Emerging Issues in COVID and T Cells (Deadline: 31 July 2023)
- Immune Response to Viruses and Bacteria (Deadline: 31 July 2023)
- Pathogenesis and Treatment of Autoimmune and Inflammatory Diseases (Deadline: 31 July 2023)
- Neuroinflammation in Autoimmune Diseases (Deadline: 31 July 2023)
- Host Immune Mechanisms in Infectious and Non-infectious Diseases in Humans (Deadline: 31 July 2023)
- Inflammasome and Microbiota Functions in Skin, Mouth, and Gut Inflammation (Deadline: 31 July 2023)
- State-of-the-Art Immunology and Immunotherapy in Europe (Deadline: 31 July 2023)
- Immunonutrition: Biomedical Basis for Disease Management 2.0 (Deadline: 31 July 2023)
- The Role of Polyamines in Human Health and Disease (Deadline: 31 July 2023)
- State-of-the-Art Immunology and Immunotherapy in Poland (Deadline: 31 July 2023)
- Endothelial Dysfunction: From Pathophysiology to Novel Therapeutic Approaches 2.0 (Deadline: 31 July 2023)
- Autoimmunity and Immune-Dysregulation in Hematological Diseases (Deadline: 15 August 2023)
- T-cell Immunotherapy for Solid Tumors and Hematological Diseases (Deadline: 15 August 2023)
- Immunity to SARS-CoV-2: Humoral and Cellular Immune Response (Deadline: 15 August 2023)
- Molecular Research in Infectious Diseases (Deadline: 31 August 2023)
- Autoimmune Disease and Malignancy of the Thyroid Gland in the COVID-19 Pandemic Era (Deadline: 31 August 2023)
- Mesenchymal Stem Cells in Regenerative Medicine and Immunomodulation (Deadline: 31 August 2023)
- New Advance in Cellular and Molecular Mechanisms of Autoimmune Disease (Deadline: 31 August 2023)
- Involvement of Pro-inflammatory Mediators in Chronic Inflammatory Diseases and Related Psychiatric Disorders (Deadline: 31 August 2023)
- Renal Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches 2.0 (Deadline: 31 August 2023)
- Molecular Research and Treatment of Pediatric Dermatology (Deadline: 31 August 2023)
- The Role of Alarmins in Human Pathologies: Impact on Diagnostic and Therapeutic Approaches (Deadline: 31 August 2023)
- The Role of the Immune System in Kidney Disease: Advances in Mechanisms and Therapeutics (Deadline: 31 August 2023)
- Immune Checkpoints and Autoimmunity Volume II (Deadline: 30 September 2023)
- Advanced Biomedical Research on COVID-19 (Deadline: 30 September 2023)
- Disease Biomarkers in Immunomediated Diseases (Deadline: 30 September 2023)
- Breaking through the Barricades: Immune Checkpoint Molecules and Immunotherapy in Cancer (Deadline: 30 September 2023)
- Binding between Telocytes, Immune Cells, and Stem Cells (Deadline: 30 September 2023)
- NLRP3 Inflammasome and Inflammatory Diseases (Deadline: 30 September 2023)
- Recent Insight in Auto-Inflammatory and Autoimmune Diseases (Deadline: 30 September 2023)
- The Interplay between Immunity and Microbiota in Human Health and Diseases (Deadline: 30 September 2023)
- Autoimmune Diseases: Mechanisms and Novel Therapeutic Approaches (Deadline: 30 September 2023)
- Acute and Chronic Urticaria: New Insights into Pathogenesis, Diagnosis and Therapy (Deadline: 31 October 2023)
- Novel Biomarkers and Mechanisms Underlying HBV and HDV Infection (Deadline: 31 October 2023)
- Emerging Issues in COVID-19 and Neutralizing Antibodies (Deadline: 31 October 2023)
- Editorial Board Members' Collection Series: Immunotherapy (Deadline: 31 October 2023)
- Immunogenicities and Immunotherapies in Leukemia (Deadline: 31 October 2023)
- New Advance in Immuno-Oncology (Deadline: 31 October 2023)
- Vitamin D in Health and Disease 2.0 (Deadline: 31 October 2023)
- Mechanism and Modulation in Sepsis 2.0 (Deadline: 15 November 2023)
- Macrophages in Health and Non-infectious Disease 4.0 (Deadline: 15 November 2023)
- Stem Cells and Immunomodulation (Deadline: 15 November 2023)
- Identification and Validation of New Biomarkers to Help the Creation of Clinical Diagnostics in Autoimmune and Cancer Diseases (Deadline: 30 November 2023)
- Trained Immunity and Endotoxin Tolerance in Inflammatory Diseases (Deadline: 30 November 2023)
- Advances in Macrophage-Based Immunotherapy (Deadline: 30 November 2023)
- Vaccines against Infectious Diseases: Current Research and Future Perspectives (Deadline: 30 November 2023)
- Neutrophils, Fast and Strong 2.0 (Deadline: 30 November 2023)
- Inflammasome as a Promising Therapeutic Target (Deadline: 31 December 2023)
- Immunomodulatory Potential of Essential Oils and Their Compounds (Deadline: 31 December 2023)
Topical Collections
Following topical collections within this section are currently open for submissions:
